Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
European Journal of Cancer (Oxford, England : 1990)|October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trialRachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinomaDanny Rischin, Aaron R Hansen, Ezra E W Cohen, et al.
Cancer Research|February 19, 2015
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer PatientsAbdullah A Osman, David M Neskey, Panagiotis Katsonis, et al.
The Lancet. Oncology|April 1, 2024
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trialJean-Pascal Machiels, Yungan Tao, Lisa Licitra, et al.
Oral Oncology|February 21, 2026
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion)Panagiota Economopoulou, Abraham Pouliakis, Miltiades Kyprianou, et al.
Head & Neck|May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase IIISusanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.
The Lancet Regional Health. Europe|February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACANJean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
Head & Neck|October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU ProjectStefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Lisa Licitra, Kevin Harrington, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2024
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important changeSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Pageof 30